+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Intermittent Catheter Market by Product, Indication, Category, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030

  • PDF Icon

    Report

  • 270 Pages
  • February 2022
  • Region: Global
  • Allied Market Research
  • ID: 5578246
UP TO OFF until Jan 30th 2025
The global intermittent catheter market was valued at $2,031.87 million in 2020, and is estimated to reach $ 3,319.32 million by 2030, growing at a CAGR of 5.1% from 2021 to 2030.

Intermittent catheter is a disposable medical device, which is used to drain the urine from the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to collect the urine. These catheters are composed of silicone, polyvinyl chloride(PVC) or vinyl, or red rubber latex.

The growth of the intermittent catheters market is driven by increase in incidences of urinary incontinence, rise in geriatric population, and surge in need for minimally invasive surgeries. In addition, increase in preference of hydrophilic intermittent catheters is expected to supplement the market growth. However, the availability of alternatives to intermittent catheters and lack of awareness toward novel intermittent catheters impede the market growth. On the contrary, innovations in catheters and novel product launches are anticipated to provide lucrative opportunities for the market expansion.

The intermittent catheters market is segmented on the basis of product, indication, category, end user, and region. By product, it is bifurcated into uncoated intermittent catheter and coated intermittent catheter. Coated intermittent catheters are further classified into antimicrobial, hydrophilic, and others. Depending on indication, it is categorized into urinary incontinence, spinal cord injuries, general surgery, and others.

As per category, it is classified into female length catheter, male length catheter, and kid length catheter. According to end user, it is fragmented into hospitals, ambulatory surgical centers, and medical research centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global intermittent catheter market size along with the current trends and future estimations to elucidate the imminent investment pockets
  • It offers market forecast analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global intermittent catheter market

KEY MARKET SEGMENTS


By Product

  • Uncoated Intermittent Catheter
  • Coated Intermittent Catheter
  • Antimocrobial
  • Hydrophilic
  • Others

By Indication

  • Urinary Incontinence
  • Surgery (Major Surgery)
  • Spinal Cord Injury
  • Others (Include Multiple Sclerosis and Spina Bifida)
  • End Users
  • Hospitals
  • Medical Research Centers
  • Ambulatory Surgical Centers

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Adapta medica
  • B Braun Melsunge
  • Becton, Dickinson and company
  • Coloplast
  • ConvaTec
  • Cure Medical,
  • Hollister
  • Hunter Urology
  • Pennine Healthcare
  • Teleflex

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
Chapter 4: Intermittent Catheters Market, by Products
4.1. Market Overview
4.1.1 Market Size and Forecast, by Products
4.2. Uncoated Intermittent Catheter
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Coated Intermittent Catheter
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
4.3.4. Antimicrobial
4.3.4.1. Market Size and Forecast
4.3.5. Hydrophilic
4.3.5.1. Market Size and Forecast
4.3.6. Others
4.3.6.1. Market Size and Forecast
Chapter 5: Intermittent Catheters Market, by Indication
5.1. Market Overview
5.1.1 Market Size and Forecast, by Indication
5.2. Urinary Incontinence
5.2.1. Market Size and Forecast, by Region
5.2.3. Market Share Analysis, by Country
5.3. Surgery
5.3.2. Market Size and Forecast, by Region
5.3.3. Market Share Analysis, by Country
5.4. Spinal Cord Injury
5.4.1. Market Size and Forecast, by Region
5.4.3. Market Share Analysis, by Country
5.5. Others
5.5.1. Market Size and Forecast, by Region
5.5.3. Market Share Analysis, by Country
Chapter 6: Intermittent Catheters Market, by Category
6.1. Market Overview
6.1.1 Market Size and Forecast, by Category
6.2. Male Length Catheter
6.2.1. Market Size and Forecast, by Region
6.2.3. Market Share Analysis, by Country
6.3. Kids Length Catheter
6.3.1. Market Size and Forecast, by Region
6.3.3. Market Share Analysis, by Country
6.4. Female Length Catheter
6.4.1. Market Size and Forecast, by Region
6.4.3. Market Share Analysis, by Country
Chapter 7: Intermittent Catheters Market, by End-user
7.1. Market Overview
7.1.1 Market Size and Forecast, by End-user
7.2. Hospitals
7.2.1. Market Size and Forecast, by Region
7.2.3. Market Share Analysis, by Country
7.3. Medical Research Centers
7.3.1. Market Size and Forecast, by Region
7.3.3. Market Share Analysis, by Country
7.4. Ambulatory Surgical Centers
7.4.1. Market Size and Forecast, by Region
7.4.3. Market Share Analysis, by Country
Chapter 8: Intermittent Catheters Market, by Region
8.1. Market Overview
8.1.1 Market Size and Forecast, by Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, by Products
8.2.3. Market Size and Forecast, by Indication
8.2.4. Market Size and Forecast, by Category
8.2.5. Market Size and Forecast, by End-user
8.2.6. Market Size and Forecast, by Country
8.2.7. U. S. Intermittent Catheters Market
8.2.7.1. Market Size and Forecast, by Products
8.2.7.2. Market Size and Forecast, by Indication
8.2.7.3. Market Size and Forecast, by Category
8.2.7.4. Market Size and Forecast, by End-user
8.2.8. Canada Intermittent Catheters Market
8.2.8.1. Market Size and Forecast, by Products
8.2.8.2. Market Size and Forecast, by Indication
8.2.8.3. Market Size and Forecast, by Category
8.2.8.4. Market Size and Forecast, by End-user
8.2.9. Mexico Intermittent Catheters Market
8.2.9.1. Market Size and Forecast, by Products
8.2.9.2. Market Size and Forecast, by Indication
8.2.9.3. Market Size and Forecast, by Category
8.2.9.4. Market Size and Forecast, by End-user
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, by Products
8.3.3. Market Size and Forecast, by Indication
8.3.4. Market Size and Forecast, by Category
8.3.5. Market Size and Forecast, by End-user
8.3.6. Market Size and Forecast, by Country
8.3.7. Germany Intermittent Catheters Market
8.3.7.1. Market Size and Forecast, by Products
8.3.7.2. Market Size and Forecast, by Indication
8.3.7.3. Market Size and Forecast, by Category
8.3.7.4. Market Size and Forecast, by End-user
8.3.8. France Intermittent Catheters Market
8.3.8.1. Market Size and Forecast, by Products
8.3.8.2. Market Size and Forecast, by Indication
8.3.8.3. Market Size and Forecast, by Category
8.3.8.4. Market Size and Forecast, by End-user
8.3.9. UK Intermittent Catheters Market
8.3.9.1. Market Size and Forecast, by Products
8.3.9.2. Market Size and Forecast, by Indication
8.3.9.3. Market Size and Forecast, by Category
8.3.9.4. Market Size and Forecast, by End-user
8.3.10. Italy Intermittent Catheters Market
8.3.10.1. Market Size and Forecast, by Products
8.3.10.2. Market Size and Forecast, by Indication
8.3.10.3. Market Size and Forecast, by Category
8.3.10.4. Market Size and Forecast, by End-user
8.3.11. Spain Intermittent Catheters Market
8.3.11.1. Market Size and Forecast, by Products
8.3.11.2. Market Size and Forecast, by Indication
8.3.11.3. Market Size and Forecast, by Category
8.3.11.4. Market Size and Forecast, by End-user
8.3.12. Rest of Europe Intermittent Catheters Market
8.3.12.1. Market Size and Forecast, by Products
8.3.12.2. Market Size and Forecast, by Indication
8.3.12.3. Market Size and Forecast, by Category
8.3.12.4. Market Size and Forecast, by End-user
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, by Products
8.4.3. Market Size and Forecast, by Indication
8.4.4. Market Size and Forecast, by Category
8.4.5. Market Size and Forecast, by End-user
8.4.6. Market Size and Forecast, by Country
8.4.7. Japan Intermittent Catheters Market
8.4.7.1. Market Size and Forecast, by Products
8.4.7.2. Market Size and Forecast, by Indication
8.4.7.3. Market Size and Forecast, by Category
8.4.7.4. Market Size and Forecast, by End-user
8.4.8. China Intermittent Catheters Market
8.4.8.1. Market Size and Forecast, by Products
8.4.8.2. Market Size and Forecast, by Indication
8.4.8.3. Market Size and Forecast, by Category
8.4.8.4. Market Size and Forecast, by End-user
8.4.9. Australia Intermittent Catheters Market
8.4.9.1. Market Size and Forecast, by Products
8.4.9.2. Market Size and Forecast, by Indication
8.4.9.3. Market Size and Forecast, by Category
8.4.9.4. Market Size and Forecast, by End-user
8.4.10. India Intermittent Catheters Market
8.4.10.1. Market Size and Forecast, by Products
8.4.10.2. Market Size and Forecast, by Indication
8.4.10.3. Market Size and Forecast, by Category
8.4.10.4. Market Size and Forecast, by End-user
8.4.11. South Korea Intermittent Catheters Market
8.4.11.1. Market Size and Forecast, by Products
8.4.11.2. Market Size and Forecast, by Indication
8.4.11.3. Market Size and Forecast, by Category
8.4.11.4. Market Size and Forecast, by End-user
8.4.12. Rest of Asia-Pacific Intermittent Catheters Market
8.4.12.1. Market Size and Forecast, by Products
8.4.12.2. Market Size and Forecast, by Indication
8.4.12.3. Market Size and Forecast, by Category
8.4.12.4. Market Size and Forecast, by End-user
8.5. Lamea
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, by Products
8.5.3. Market Size and Forecast, by Indication
8.5.4. Market Size and Forecast, by Category
8.5.5. Market Size and Forecast, by End-user
8.5.6. Market Size and Forecast, by Country
8.5.7. Brazil Intermittent Catheters Market
8.5.7.1. Market Size and Forecast, by Products
8.5.7.2. Market Size and Forecast, by Indication
8.5.7.3. Market Size and Forecast, by Category
8.5.7.4. Market Size and Forecast, by End-user
8.5.8. South Africa, Intermittent Catheters Market
8.5.8.1. Market Size and Forecast, by Products
8.5.8.2. Market Size and Forecast, by Indication
8.5.8.3. Market Size and Forecast, by Category
8.5.8.4. Market Size and Forecast, by End-user
8.5.9. Saudi Arabia Intermittent Catheters Market
8.5.9.1. Market Size and Forecast, by Products
8.5.9.2. Market Size and Forecast, by Indication
8.5.9.3. Market Size and Forecast, by Category
8.5.9.4. Market Size and Forecast, by End-user
8.5.10. Rest of LAMEA Intermittent Catheters Market
8.5.10.1. Market Size and Forecast, by Products
8.5.10.2. Market Size and Forecast, by Indication
8.5.10.3. Market Size and Forecast, by Category
8.5.10.4. Market Size and Forecast, by End-user
Chapter 9: Company Profiles
9.1. Adapta Medical
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. B. Braun Melsunges AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Becton, Dickinson and Company
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Coloplast
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Convatec Limited
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Cure Medical
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Hollister Incorporated
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Hunter Urology
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Pennine Healthcare
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Teleflex, Inc
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
List of Tables
Table 1. Global Intermittent Catheters Market, by Products, 2020-2030 ($Million)
Table 2. Global Intermittent Catheters Market for Uncoated Intermittent Catheter, by Region, 2020-2030 ($Million)
Table 3. Global Intermittent Catheters Market for Coated Intermittent Catheter, by Region, 2020-2030 ($Million)
Table 4. Global Intermittent Catheters Market, by Indication, 2020-2030 ($Million)
Table 5. Global Intermittent Catheters Market for Urinary Incontinence, by Region, 2020-2030 ($Million)
Table 6. Global Intermittent Catheters Market for Surgery, by Region, 2020-2030 ($Million)
Table 7. Global Intermittent Catheters Market for Spinal Cord Injury, by Region, 2020-2030 ($Million)
Table 8. Global Intermittent Catheters Market for Others, by Region, 2020-2030 ($Million)
Table 9. Global Intermittent Catheters Market, by Category, 2020-2030 ($Million)
Table 10. Global Intermittent Catheters Market for Male Length Catheter, by Region, 2020-2030 ($Million)
Table 11. Global Intermittent Catheters Market for Kids Length Catheter, by Region, 2020-2030 ($Million)
Table 12. Global Intermittent Catheters Market for Female Length Catheter, by Region, 2020-2030 ($Million)
Table 13. Global Intermittent Catheters Market, by End-user, 2020-2030 ($Million)
Table 14. Global Intermittent Catheters Market for Hospitals, by Region, 2020-2030 ($Million)
Table 15. Global Intermittent Catheters Market for Medical Research Centers, by Region, 2020-2030 ($Million)
Table 16. Global Intermittent Catheters Market for Ambulatory Surgical Centers, by Region, 2020-2030 ($Million)
Table 17. Global Intermittent Catheters Market, by Region, 2020-2030 ($Million)
Table 18. North America Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 19. North America Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 20. North America Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 21. North America Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 22. U.S Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 23. U.S Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 24. U.S Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 25. U.S Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 26. Canada Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 27. Canada Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 28. Canada Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 29. Canada Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 30. Mexico Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 31. Mexico Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 32. Mexico Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 33. Mexico Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 34. Europe Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 35. Europe Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 36. Europe Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 37. Europe Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 38. Germany Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 39. Germany Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 40. Germany Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 41. Germany Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 42. France Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 43. France Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 44. France Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 45. France Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 46. Uk Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 47. Uk Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 48. Uk Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 49. Uk Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 50. Italy Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 51. Italy Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 52. Italy Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 53. Italy Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 54. Spain Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 55. Spain Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 56. Spain Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 57. Spain Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 58. Rest of Europe Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 59. Rest of Europe Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 60. Rest of Europe Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 61. Rest of Europe Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 62. Asia-Pacific Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 63. Asia-Pacific Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 64. Asia-Pacific Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 65. Asia-Pacific Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 66. Japan Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 67. Japan Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 68. Japan Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 69. Japan Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 70. China Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 71. China Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 72. China Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 73. China Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 74. Australia Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 75. Australia Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 76. Australia Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 77. Australia Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 78. India Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 79. India Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 80. India Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 81. India Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 82. South Korea Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 83. South Korea Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 84. South Korea Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 85. South Korea Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 86. Rest of Asia-Pacific Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 87. Rest of Asia-Pacific Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 88. Rest of Asia-Pacific Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 89. Rest of Asia-Pacific Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 90. Lamea Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 91. Lamea Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 92. Lamea Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 93. Lamea Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 94. Brazil Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 95. Brazil Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 96. Brazil Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 97. Brazil Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 98. South Africa, Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 99. South Africa, Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 100. South Africa, Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 101. South Africa, Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 102. Saudi Arabia Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 103. Saudi Arabia Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 104. Saudi Arabia Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 105. Saudi Arabia Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 106. Rest of LAMEA Intermittent Catheters, by Products, 2020-2030 ($Million)
Table 107. Rest of LAMEA Intermittent Catheters, by Indication, 2020-2030 ($Million)
Table 108. Rest of LAMEA Intermittent Catheters, by Category, 2020-2030 ($Million)
Table 109. Rest of LAMEA Intermittent Catheters, by End-user, 2020-2030 ($Million)
Table 110. Adapta Medical: Key Executives
Table 111. Adapta Medical: Company Snapshot
Table 112. Adapta Medical: Operating Segments
Table 113. Adapta Medical: Product Portfolio
Table 114. Adapta Medical: Key Strategic Moves and Developments
Table 115. B. Braun Melsunges Ag: Key Executives
Table 116. B. Braun Melsunges Ag: Company Snapshot
Table 117. B. Braun Melsunges Ag: Operating Segments
Table 118. B. Braun Melsunges Ag: Product Portfolio
Table 119. B. Braun Melsunges Ag: Key Strategic Moves and Developments
Table 120. Becton, Dickinson and Company: Key Executives
Table 121. Becton, Dickinson and Company: Company Snapshot
Table 122. Becton, Dickinson and Company: Operating Segments
Table 123. Becton, Dickinson and Company: Product Portfolio
Table 124. Becton, Dickinson and Company: Key Strategic Moves and Developments
Table 125. Coloplast: Key Executives
Table 126. Coloplast: Company Snapshot
Table 127. Coloplast: Operating Segments
Table 128. Coloplast: Product Portfolio
Table 129. Coloplast: Key Strategic Moves and Developments
Table 130. Convatec Limited: Key Executives
Table 131. Convatec Limited: Company Snapshot
Table 132. Convatec Limited: Operating Segments
Table 133. Convatec Limited: Product Portfolio
Table 134. Convatec Limited: Key Strategic Moves and Developments
Table 135. Cure Medical: Key Executives
Table 136. Cure Medical: Company Snapshot
Table 137. Cure Medical: Operating Segments
Table 138. Cure Medical: Product Portfolio
Table 139. Cure Medical: Key Strategic Moves and Developments
Table 140. Hollister Incorporated: Key Executives
Table 141. Hollister Incorporated: Company Snapshot
Table 142. Hollister Incorporated: Operating Segments
Table 143. Hollister Incorporated: Product Portfolio
Table 144. Hollister Incorporated: Key Strategic Moves and Developments
Table 145. Hunter Urology: Key Executives
Table 146. Hunter Urology: Company Snapshot
Table 147. Hunter Urology: Operating Segments
Table 148. Hunter Urology: Product Portfolio
Table 149. Hunter Urology: Key Strategic Moves and Developments
Table 150. Pennine Healthcare: Key Executives
Table 151. Pennine Healthcare: Company Snapshot
Table 152. Pennine Healthcare: Operating Segments
Table 153. Pennine Healthcare: Product Portfolio
Table 154. Pennine Healthcare: Key Strategic Moves and Developments
Table 155. Teleflex, Inc: Key Executives
Table 156. Teleflex, Inc: Company Snapshot
Table 157. Teleflex, Inc: Operating Segments
Table 158. Teleflex, Inc: Product Portfolio
Table 159. Teleflex, Inc: Key Strategic Moves and Developments
List of Figures
Figure 1. Global Intermittent Catheters Market Segmentation
Figure 2. Global Intermittent Catheters Market
Figure 3. Segmentation Intermittent Catheters Market
Figure 4. Top Investment Pocket in Intermittent Catheters Market
Figure 5. Top Winning Strategies, 2019-2021*
Figure 6. Top Winning Strategies, by Development, 2019-2021(%)
Figure 7. Top Winning Strategies, by Company, 2019-2021*
Figure 8. Moderate Bargaining Power of Buyers
Figure 9. Moderate Bargaining Power of Suppliers
Figure 10. Moderate Threat of New Entrants
Figure 11. Low Threat of Substitution
Figure 12. High Competitive Rivalry
Figure 13. Top Player Positioning, 2020
Figure 14. Market Share Analysis, 2020
Figure 15. Restraints and Drivers: Intermittent Catheters Market
Figure 16. Intermittent Catheters Market Segmentation, by Products
Figure 17. Intermittent Catheters Market for Uncoated Intermittent Catheter, by Country, 2020-2030 ($ Million)
Figure 18. Intermittent Catheters Market for Coated Intermittent Catheter, by Country, 2020-2030 ($ Million)
Figure 19. Intermittent Catheters Market Segmentation, by Indication
Figure 20. Intermittent Catheters Market for Urinary Incontinence, by Country, 2020-2030 ($ Million)
Figure 21. Intermittent Catheters Market for Surgery, by Country, 2020-2030 ($ Million)
Figure 22. Intermittent Catheters Market for Spinal Cord Injury, by Country, 2020-2030 ($ Million)
Figure 23. Intermittent Catheters Market for Others, by Country, 2020-2030 ($ Million)
Figure 24. Intermittent Catheters Market Segmentation, by Category
Figure 25. Intermittent Catheters Market for Male Length Catheter, by Country, 2020-2030 ($ Million)
Figure 26. Intermittent Catheters Market for Kids Length Catheter, by Country, 2020-2030 ($ Million)
Figure 27. Intermittent Catheters Market for Female Length Catheter, by Country, 2020-2030 ($ Million)
Figure 28. Intermittent Catheters Market Segmentation, by End-user
Figure 29. Intermittent Catheters Market for Hospitals, by Country, 2020-2030 ($ Million)
Figure 30. Intermittent Catheters Market for Medical Research Centers, by Country, 2020-2030 ($ Million)
Figure 31. Intermittent Catheters Market for Ambulatory Surgical Centers, by Country, 2020-2030 ($ Million)
Figure 32. Adapta Medical: Net Sales, 2018-2020 ($ Million)
Figure 33. Adapta Medical: Revenue Share, by Segment, 2020 (%)
Figure 34. Adapta Medical: Revenue Share, by Region, 2020 (%)
Figure 35. B. Braun Melsunges Ag: Net Sales, 2018-2020 ($ Million)
Figure 36. B. Braun Melsunges Ag: Revenue Share, by Segment, 2020 (%)
Figure 37. B. Braun Melsunges Ag: Revenue Share, by Region, 2020 (%)
Figure 38. Becton, Dickinson and Company: Net Sales, 2018-2020 ($ Million)
Figure 39. Becton, Dickinson and Company: Revenue Share, by Segment, 2020 (%)
Figure 40. Becton, Dickinson and Company: Revenue Share, by Region, 2020 (%)
Figure 41. Coloplast: Net Sales, 2018-2020 ($ Million)
Figure 42. Coloplast: Revenue Share, by Segment, 2020 (%)
Figure 43. Coloplast: Revenue Share, by Region, 2020 (%)
Figure 44. Convatec Limited: Net Sales, 2018-2020 ($ Million)
Figure 45. Convatec Limited: Revenue Share, by Segment, 2020 (%)
Figure 46. Convatec Limited: Revenue Share, by Region, 2020 (%)
Figure 47. Cure Medical: Net Sales, 2018-2020 ($ Million)
Figure 48. Cure Medical: Revenue Share, by Segment, 2020 (%)
Figure 49. Cure Medical: Revenue Share, by Region, 2020 (%)
Figure 50. Hollister Incorporated: Net Sales, 2018-2020 ($ Million)
Figure 51. Hollister Incorporated: Revenue Share, by Segment, 2020 (%)
Figure 52. Hollister Incorporated: Revenue Share, by Region, 2020 (%)
Figure 53. Hunter Urology: Net Sales, 2018-2020 ($ Million)
Figure 54. Hunter Urology: Revenue Share, by Segment, 2020 (%)
Figure 55. Hunter Urology: Revenue Share, by Region, 2020 (%)
Figure 56. Pennine Healthcare: Net Sales, 2018-2020 ($ Million)
Figure 57. Pennine Healthcare: Revenue Share, by Segment, 2020 (%)
Figure 58. Pennine Healthcare: Revenue Share, by Region, 2020 (%)
Figure 59. Teleflex, Inc: Net Sales, 2018-2020 ($ Million)
Figure 60. Teleflex, Inc: Revenue Share, by Segment, 2020 (%)
Figure 61. Teleflex, Inc: Revenue Share, by Region, 2020 (%)

Executive Summary

According to a new report titled, “Intermittent Catheter Market by Product, Indication, Category, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030, The global Intermittent Catheters market was valued at $2,031.87 million in 2020, and is projected to reach $3,038.41 million by 2030, registering a CAGR of 4.1% from 2021 to 2030.

Intermittent catheter is a medical device, which helps to drain the urine from the urinary bladder in patients who lose control over their bladder. These catheters are inserted into the urethra and are guided to the bladder, which causes the urine to flow though the catheter tube and drain into the collection bag. Moreover, self-catheterization is possible using these catheters. Children aged between 7-8 years can be trained to handle catheterization.

The major driving factors of intermittent catheter market include increase in geriatric population and rise in urinary incontinence. Furthermore, the introduction of favorable reimbursement policies for catheters is expected to supplement the market growth. However, the availability of alternatives to intermittent catheters and price competition at domestic level hamper the market growth. Conversely, the emerging economies are anticipated to offer lucrative opportunities, owing to rise is disposable income and increase in awareness toward intermittent catheters.

The global intermittent catheter market is segmented on the basis of product, indication, category, and end users. Depending on the product, it is divided into uncoated intermittent catheter and coated intermittent catheter, where coated intermittent catheter is subdivided into antimicrobial, hydrophilic, and others. By indication, it is segmented into urinary incontinence, surgery, spinal cord injury, and others which include multiple sclerosis and spina bifida. According to category, it is classified into male length catheter, kids length catheter, and female length catheter. As per end users, it is fragmented into hospitals, medical research centers, and ambulatory surgical centers.

By product type, coated intermittent catheter is the dominant segment in the intermittent catheter market. Coated catheters reduce bacterial adhesion due to their low coefficient of friction and are biocompatible & durable. Moreover, these coated catheters are solvent resistant, facilitate aqueous interactions, have low coefficients of friction, and eliminate thrombosis.

Depending on indication, urinary incontinence is the dominant segment in the intermittent catheter market owing to the increase in prevalence of urological disorders across the globe.

According to the category, female length catheters incontinence is the dominant segment in the intermittent catheter market, owing to increase in prevalence of UTI in females. For instance, according to the American Urological Association, one-third of the population suffers from UI, and it is more common among women compared to men.

As per end user, hospital is the dominant segment in the intermittent catheter market due to increase in number of patients affected by renal disease, urinary tract infections, increase in the geriatric population, urethral obstructions, and rise in cases of tumor..

Key Findings Of The Study


  • By product, the coated intermittent catheters segment was the highest contributor to the market in 2020
  • On the basis of indication, the urine incontinence segment dominated the market in 2020, and is expected to continue this trend during the forecast period
  • Depending on end user, the hospitals segment led the market in 2020
  • Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
  • North America garnered a major share of the intermittent catheter market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of urinary incontinence, number of patients suffering from urinary tract infection, and increase in the geriatric population. However, Asia-Pacific is expected to register highest CAGR of 635% from 2021 to 2030

Companies Mentioned

  • Adapta Medica
  • B. Braun Melsunge
  • Becton
  • Dickinson and Company
  • Coloplast
  • Convatec
  • Cure Medical
  • Hollister
  • Hunter Urology
  • Pennine Healthcare
  • Teleflex.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information